FORWARD FEATURES CALENDAR

Intel

New Mountain closes Fund VII at $15.4bn

New York-headquartered alternative investment firm New Mountain Capital has held the final close of its seventh control-oriented fund, New Mountain Partners VII, with $15.4bn in capital commitments.

PAI Partners and Inveready team up to make Avatel bid

French private equity firm PAI Partners and Spanish investment firm Inveready have collaborated on a bid for Avatel, Spain’s fifth-largest telecoms company, according to a report by Expansion, citing unidentified market sources.

Partners Group acquires majority stake in €900m biotech FairJourney

Swiss private equity firm Partners Group has acquired a majority stake in FairJourney Biologics, a biotech known for its work on antibody treatments for major drugmakers such as Johnson & Johnson, in a deal that values the business at €900m, according to a report by the Financial Times.

Events

12 November, 2026 – 5:00 pm

Directory Listings